Clinical Trial Update: Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection [Phase 4]

View source ↗

Summary

This Phase 4 trial assessed the immunogenicity of the 7-valent pneumococcal conjugate vaccine in the lung fluid of adults with and without HIV; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Invasive Pneumococcal Disease
• Meningitis
• Pneumonia

Drugs mentioned

• Prevnar 7 (Pneumococcal conjugate vaccine, 7-valent)

Snippet

Sponsor: Royal Liverpool University Hospital | Conditions: Pneumonia, Meningitis | Phase 4 | Status: COMPLETED